Alexion:
PNH HCP Email

Part of an unbranded email campaign to encourage testing for PNH, a rare disease treated by a therapy from Alexion Pharmaceuticals. The campaign had the highest “open rate” among all of the client’s HCP disease state emails.

_______

Coombs-negative hemolytic anemia is the clinical hallmark of a rare and potentially deadly disease called paroxysmal nocturnal hemoglobinuria (PNH).

Approximately 20% to 35% of patients with PNH die within 6 years of diagnosis despite historical supportive care. Although PNH is uncommon,18.6% (71/382) of patients with Coombs negative hemolytic anemia have been shown to test positive for a PNH clone.